Return to homepagePandemic Pact

Use of molecular tool and development of heterologous anti-Sars-Cov-2 serum as COVID-19 coping strategy

Grant number: APQ-00399-20

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $37,602.59

  • Funder

    FAPEMIG Brazil

  • Principal Investigator

    Sérgio Caldas

  • Research Location

    Brazil

  • Lead Research Institution

    Fundação Ezequiel Dias

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

Integrated workflow for production and in vitro characterization of equine anti-SARS-CoV-2 hyperimmune serum with epitope mapping.